Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...
Morning Overview on MSN
AI coder Replit seeks $400M war chest in blockbuster funding bid
Replit is racing to turn its AI coding tools into a full-stack software factory, and investors appear ready to bankroll that ambition at massive scale. The company is seeking a fresh $400 million ...
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback